z-logo
Premium
Brentuximab vedotin as consolidation after hematopoietic cell transplant for relapsed Hodgkin lymphoma in pediatric patients
Author(s) -
Flerlage Jamie E.,
Buttlar Xinyu,
Krasin Matthew,
Triplett Brandon,
Kaste Sue C.,
Metzger Monika L.
Publication year - 2019
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.27962
Subject(s) - medicine , brentuximab vedotin , hematopoietic cell , hodgkin lymphoma , lymphoma , oncology , hematopoietic stem cell transplantation , lymphoblastic lymphoma , transplantation , haematopoiesis , immunology , t cell , stem cell , immune system , biology , genetics

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom